Nutex Investments PLC
NUTEX Investments Public Limited Company provides health preserving, health improving, dietary supplement, and cosmetic products in Hungary and internationally. The company was formerly known as HUMET Trade, Research and Development Public Limited Company and changed its name to NUTEX Investments Public Limited Company in February 2011. The company was incorporated in 1996 and is based in Budapes… Read more
Nutex Investments PLC (NUTEX) - Net Assets
Latest net assets as of December 2024: Ft4.96 Billion HUF
Based on the latest financial reports, Nutex Investments PLC (NUTEX) has net assets worth Ft4.96 Billion HUF as of December 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Ft5.00 Billion) and total liabilities (Ft42.42 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Ft4.96 Billion |
| % of Total Assets | 99.15% |
| Annual Growth Rate | 28.02% |
| 5-Year Change | 37.5% |
| 10-Year Change | N/A |
| Growth Volatility | 38.22 |
Nutex Investments PLC - Net Assets Trend (2018–2024)
This chart illustrates how Nutex Investments PLC's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Nutex Investments PLC (2018–2024)
The table below shows the annual net assets of Nutex Investments PLC from 2018 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | Ft4.96 Billion | -9.42% |
| 2023-12-31 | Ft5.47 Billion | +3.23% |
| 2022-12-31 | Ft5.30 Billion | +2.58% |
| 2021-12-31 | Ft5.17 Billion | +43.35% |
| 2020-12-31 | Ft3.60 Billion | +97.94% |
| 2019-12-31 | Ft1.82 Billion | +61.80% |
| 2018-12-31 | Ft1.13 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Nutex Investments PLC's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 397535300000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | Ft3.98 Billion | 80.21% |
| Other Components | Ft980.59 Million | 19.79% |
| Total Equity | Ft4.96 Billion | 100.00% |
Nutex Investments PLC Competitors by Market Cap
The table below lists competitors of Nutex Investments PLC ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Alice QUEEN Ltd
AU:AQX
|
$3.53 Million |
|
Next Technology Holding Inc
NASDAQ:NXTT
|
$3.54 Million |
|
CHA0
F:CHA0
|
$3.54 Million |
|
Eshallgo Inc. Class A Ordinary Shares
NASDAQ:EHGO
|
$3.54 Million |
|
Rapac Communication & Infrastructure Ltd
TA:RPAC
|
$3.53 Million |
|
Armada Mercantile Ltd
PINK:AAMTF
|
$3.53 Million |
|
Active Biotech AB (publ)
F:BTPC
|
$3.53 Million |
|
Pixie Dust Technologies, Inc. American Depositary Shares
NASDAQ:PXDT
|
$3.53 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Nutex Investments PLC's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 5,471,533,000 to 4,955,939,000, a change of -515,594,000 (-9.4%).
- Net income of 423,412,000 contributed positively to equity growth.
- Share repurchases of 342,000,000 reduced equity.
- Other factors decreased equity by 597,006,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Ft423.41 Million | +8.54% |
| Share Repurchases | Ft342.00 Million | -6.9% |
| Other Changes | Ft-597.01 Million | -12.05% |
| Total Change | Ft- | -9.42% |
Book Value vs Market Value Analysis
This analysis compares Nutex Investments PLC's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.39x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has increased from 0.22x to 0.39x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2018-12-31 | Ft68.85 | Ft15.00 | x |
| 2019-12-31 | Ft49.00 | Ft15.00 | x |
| 2020-12-31 | Ft39.42 | Ft15.00 | x |
| 2021-12-31 | Ft34.89 | Ft15.00 | x |
| 2022-12-31 | Ft35.79 | Ft15.00 | x |
| 2023-12-31 | Ft36.94 | Ft15.00 | x |
| 2024-12-31 | Ft38.09 | Ft15.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Nutex Investments PLC utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 8.54%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 94091.56%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 1.01x
- Recent ROE (8.54%) is above the historical average (-2.67%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2018 | -33.38% | -9096.42% | 0.00x | 1.02x | Ft-488.23 Million |
| 2019 | -0.44% | -1068.40% | 0.00x | 1.00x | Ft-190.11 Million |
| 2020 | 0.72% | 5797.11% | 0.00x | 1.00x | Ft-334.35 Million |
| 2021 | 0.25% | 2819.33% | 0.00x | 1.00x | Ft-504.00 Million |
| 2022 | 2.52% | 29672.44% | 0.00x | 1.00x | Ft-396.51 Million |
| 2023 | 3.13% | 38027.56% | 0.00x | 1.00x | Ft-376.03 Million |
| 2024 | 8.54% | 94091.56% | 0.00x | 1.01x | Ft-72.18 Million |
Industry Comparison
This section compares Nutex Investments PLC's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
No peer company data available for comparison.